STOCK TITAN

National Health Investors (NHI) Financials

NHI NYSE
FY2025 annual
Revenue $375.6M +12.1% YoY
Net Income $142.2M +3.0% YoY
EPS (Diluted) $3.02 -3.5% YoY
Free Cash Flow -$57.5M -215.3% YoY
Market Cap $3.0B as of Nov 19, 2026
Price / Sales 6.6x on $455.8M revenue, trailing 12 months to September 30, 2026
Price / Earnings 4.3x on $697.5M net income, trailing 12 months to September 30, 2026
Price / Book 1.4x on $2.1B equity, Q3 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Nov 19, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q3 FY2026, ended Sep 30, 2026 Reported Currency USD FYE December

Newest figures come from the 10-Q for Q3 FY2026, filed Nov 9, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the NHI SEC filings page.

National Health Investors (NHI) reported $375.6M in revenue for fiscal year 2025, up 12.1% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI NHI FY2025

National Health Investors converts reported profit into cash, but escalating property investment now absorbs more cash than operations produce.

From FY2023 to FY2025, revenue increased 17.4% but net income increased only 4.8%, showing that added scale produced far less bottom-line growth. Over the same span, operating cash flow rose 28.3% while capital expenditures increased 493.3%; the resulting cash squeeze is an investment effect, not an operating cash-generation problem.

The balance sheet became less liability-heavy: liabilities were 44.9% of assets in FY2025 versus 48.8% in FY2023. Across that span, equity rose 21.3% while liabilities rose 3.5%, so asset growth leaned more on equity than additional liabilities.

FY2025 operating cash flow reached $236.6M against capital expenditures of $294.0M. Free cash flow was negative at -$57.5M despite operating cash flow equaling 166.4% of net income, showing the shortfall arose after operations.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

FFO Margin FFOGrowth Leverage Interest Cov. AFFOMargin DividendCov. 50 / 100
Financial Health Score (4 of 6 dimensions) 50/100
Scored as: REITs peer group

Scored against REITs for FY2025. Each of the six dimensions is a percentile rank within that peer group, and the overall is the average of the dimensions that can be computed: here 4 of 6, with the others left out rather than counted as zero. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of National Health Investors's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

FFO Margin
90

FFO Margin measures funds from operations against revenue, and funds from operations here is net income with all depreciation and amortization and real estate impairments added back and gains on property sales taken out, since a building written down a little further every year on paper is often worth more rather than less. National Health Investors scores 90/100 on it among other REITs.

FFO Growth
44

FFO Growth follows the three-year path of funds from operations, which here is net income with all depreciation and amortization and real estate impairments added back and gains on property sales taken out. National Health Investors scores 44/100 on it among other REITs.

Leverage
n/a

Not available for National Health Investors, so it is left out of the overall score, which averages the 4 of 6 dimensions that can be computed.

Interest Cov.
n/a

Not available for National Health Investors, so it is left out of the overall score, which averages the 4 of 6 dimensions that can be computed.

AFFO Margin
27

AFFO Margin takes funds from operations, subtracts the spending a REIT needs just to keep its properties in working order, and measures what is left against revenue. National Health Investors scores 27/100 on it among other REITs.

Dividend Cov.
39

Dividend coverage measures funds from operations against the dividends actually paid, and a figure above 1 means the payout came out of operations. National Health Investors scores 39/100 on it among other REITs.

Piotroski F-Score Partial
4/6

National Health Investors passes 4 of 6 computable financial strength tests (3 of the nine could not be computed from available data). 3 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), the one computable operating efficiency signal (asset turnover improving) passes.

Earnings Quality Cash-Backed
1.66x

For every $1 of reported earnings, National Health Investors generates $1.66 in operating cash flow ($236.6M OCF vs $142.2M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$113.5M
YoY+26.3%
QoQ-6.5%
5Y CAGR+9.0%
10Y CAGR+6.0%

National Health Investors generated $113.5M in revenue in Q3 2026. This represents an increase of 26.3% from the same quarter a year earlier. Against the prior quarter it is down 6.5%.

Net Income
$563.5M
YoY+1614.8%
QoQ+912.2%
5Y CAGR+78.8%
10Y CAGR+32.8%

National Health Investors reported $563.5M in net income in Q3 2026. This represents an increase of 1614.8% from the same quarter a year earlier. Against the prior quarter it is up 912.2%.

EPS (Diluted)
$11.47
YoY+1562.3%
QoQ+897.4%
5Y CAGR+76.5%
10Y CAGR+30.0%

National Health Investors earned $11.47 per diluted share (EPS) in Q3 2026. This represents an increase of 1562.3% from the same quarter a year earlier. Against the prior quarter it is up 897.4%.

EBITDA

Not reported for Q3 2026.

Cash & Balance Sheet

Cash & Debt
$46.6M
YoY-43.0%
QoQ+53.2%
5Y CAGR-0.8%
10Y CAGR+27.2%

National Health Investors held $46.6M in cash as of Q3 2026; no long-term debt figure is on record for that period.

Dividends Per Share
$0.94
YoY+2.2%
QoQ+2.2%
5Y CAGR+0.9%
10Y CAGR+0.4%

National Health Investors paid $0.94 per share in dividends in Q3 2026. This represents an increase of 2.2% from the same quarter a year earlier. Against the prior quarter it is up 2.2%.

Shares Outstanding
49M
YoY+3.1%
QoQ0.0%
5Y CAGR+1.4%
10Y CAGR+2.1%

National Health Investors had 49M shares outstanding in Q3 2026. This represents an increase of 3.1% from the same quarter a year earlier. It is unchanged from the prior quarter.

Free Cash Flow

Not reported for Q3 2026.

Margins & Returns

Return on Equity
27.0%
YoY+24.7pp
QoQ+23.4pp
5Y change+25.0pp
10Y change+24.2pp

National Health Investors's quarterly ROE was 27.0% in Q3 2026: one quarter's net income over shareholder equity, not annualized. This is up 24.7 percentage points from the same quarter a year earlier. Against the prior quarter it is up 23.4 percentage points.

Gross Margin

Not reported for Q3 2026.

Operating Margin

Not reported for Q3 2026.

Net Margin

Not shown for Q3 2026: the reported ratio is above 100.0% of revenue, so it does not read as a share of revenue.

Capital Allocation

None of these metrics is reported for Q3 2026.

NHI Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

NHI quarterly income statement
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Revenue$113.5M+26.3%$121.3M+33.8%$115.1M+28.9%$105.8M+23.4%$89.8M+8.3%$90.7M+6.7%$89.3M+9.5%$85.8M+7.9%
SG&A Expenses$8.0M+26.8%$8.8M+44.0%$7.9M+15.0%$7.6M+40.4%$6.3M+31.2%$6.1M+25.8%$6.8M+21.0%$5.4M+9.9%
Interest Expense$12.5M-9.0%$15.8M+5.4%$15.0M+4.9%$14.3M-6.4%$13.8M-7.9%$15.0M+1.0%$14.3M-3.6%$15.2M+2.6%
Income Tax$279Kn/m$732Kn/mN/AN/A$0$0N/AN/A
Net Income$563.5M+1614.8%$55.7M+50.5%$40.1M+17.4%$38.2M-11.7%$32.9M+15.1%$37.0M+4.9%$34.2M+10.4%$43.2M+34.9%
EPS (Basic)$11.47+1562.3%$1.15+45.6%$0.83+10.7%$0.80-16.7%$0.69+4.5%$0.79-2.5%$0.75+5.6%$0.96+29.7%
EPS (Diluted)$11.47+1562.3%$1.15+45.6%$0.82+10.8%$0.80-16.7%$0.69+6.2%$0.79-2.5%$0.74+4.2%$0.96+29.7%
Diluted Shares (Avg)49M+3.0%48M+3.6%49M+5.8%N/A48M+8.3%47M+7.5%46M+5.7%N/A

Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses, Operating Income, EBITDA.

NHI Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

NHI quarterly balance sheet
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Total Assets$3.2B+20.6%$3.0B+9.9%$2.9B+3.8%$2.8B+7.0%$2.7B+9.3%$2.7B+8.8%$2.8B+12.3%$2.6B+5.1%
Cash & Equivalents$46.6M-43.0%$30.4M+63.0%$24.9M-81.5%$19.6M-19.2%$81.6M+424.9%$18.6M+26.2%$135.0M+1088.7%$24.3M+8.7%
Total Liabilities$1.1B-4.6%$1.4B+14.7%$1.4B+1.4%$1.3B+2.3%$1.2B-1.7%$1.2B-1.2%$1.3B+10.6%$1.2B+1.2%
Total Equity$2.1B+41.1%$1.6B+6.2%$1.5B+6.2%$1.5B+11.3%$1.5B+20.5%$1.5B+18.9%$1.4B+14.3%$1.4B+9.0%
Retained Earnings$3.4B+25.7%$2.8B+6.2%$2.8B+5.6%$2.7B+5.5%$2.7B+5.7%$2.7B+5.6%$2.6B+5.7%$2.6B+5.6%

Not reported in any period shown, so not listed: Current Assets, Short-Term Investments, Inventory, Accounts Receivable, Long-Term Investments, Goodwill, Current Liabilities, Non-Current Liabilities, Long-Term Debt.

NHI Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

NHI quarterly cash flow statement
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Operating Cash Flow$48.0M-23.3%$65.0M+8.6%$53.4M+15.0%$67.7M+17.7%$62.5M+28.6%$59.8M-1.5%$46.5M+13.8%$57.6M+8.2%
Depreciation & Amortization$25.8M+27.4%$25.5M+28.3%$23.7M+23.7%$21.7M+15.9%$20.2M+13.8%$19.9M+13.9%$19.2M+9.4%$18.7M+9.2%
Stock-Based Compensation$1.5M+48.8%$2.4M+120.4%$2.2M-12.4%N/A$983K+46.7%$1.1M+55.9%$2.6M+18.7%N/A
Capital ExpendituresN/AN/A$109.4M+28.5%$143.3M+29.3%N/AN/A$85.2M$110.8M
Free Cash FlowN/AN/A-$56.0Mn/m-$75.6Mn/mN/AN/A-$38.7M-$53.3M
Investing Cash Flow$460.4M+1005.0%-$43.4Mn/m-$103.9Mn/m-$187.0Mn/m$41.7Mn/m-$48.3Mn/m-$75.5Mn/m-$161.2M-7000.6%
Financing Cash Flow-$280.5Mn/m$3.9Mn/m$55.8M-60.1%$57.3M-49.0%-$41.9Mn/m-$129.5Mn/m$139.8Mn/m$112.4Mn/m
Dividends Paid$45.2M+5.8%$44.6M+6.1%$44.4M+8.1%$43.8M+11.6%$42.7M+9.3%$42.0M+7.5%$41.1M+5.2%$39.3M+0.5%

Not reported in any period shown, so not listed: Share Buybacks.

NHI Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

NHI quarterly financial ratios
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Net Margin496.6%45.9%+5.1pp34.8%-3.4pp36.1%-14.4pp36.6%+2.2pp40.8%-0.7pp38.3%+0.3pp50.4%+10.1pp
Return on Equity27.0%+24.7pp3.5%+1.0pp2.6%+0.2pp2.5%-0.7pp2.2%-0.1pp2.5%-0.3pp2.4%-0.1pp3.2%+0.6pp
Return on Assets17.4%+16.2pp1.9%+0.5pp1.4%+0.2pp1.4%-0.3pp1.2%+0.1pp1.4%-0.1pp1.2%0.0pp1.7%+0.4pp
Liabilities-to-Equity0.54-0.3x0.88+0.1x0.900.0x0.83-0.1x0.80-0.2x0.81-0.2x0.940.0x0.90-0.1x
Asset Turnover0.040.0x0.040.0x0.040.0x0.040.0x0.030.0x0.030.0x0.030.0x0.030.0x
FCF MarginN/AN/A-48.6%-5.3pp-71.4%-9.3ppN/AN/A-43.3%-62.1%

Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Current Ratio, Debt-to-Equity.

Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Net Margin.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it. Market cap is stated at each company's latest close.

Company Fiscal year Revenue Net income Net margin Market cap Health score
National Health Investors NHI FY2025 $375.6M $142.2M 37.9% $3.0B 50/100
LTC Properties, Inc. LTC FY2025 $262.9M $118.0M 44.9% $2.4B 56/100
Sabra Healthcare REIT, Inc. SBRA FY2025 $774.6M $155.6M 20.1% $5.4B 60/100
Healthcare Realty Trust Incorporated HR FY2025 $1.2B -$246.1M -20.8% $6.6B 27/100
CareTrust REIT, Inc CTRE FY2025 $476.4M $320.5M 67.3% $9.5B 87/100
Diversified Healthcare Trust DHC FY2025 $1.5B -$285.9M -18.6% $1.7B 8/100

Frequently Asked Questions

National Health Investors (NHI) reported $375.6M in total revenue for fiscal year 2025. This represents a 12.1% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

National Health Investors (NHI) revenue grew by 12.1% year-over-year, from $335.2M to $375.6M in fiscal year 2025.

Yes, National Health Investors (NHI) reported a net income of $142.2M in fiscal year 2025, with a net profit margin of 37.9%.

National Health Investors (NHI) reported diluted earnings per share of $3.02 for fiscal year 2025. This represents a -3.5% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

National Health Investors (NHI) had a net profit margin of 37.9% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Yes, National Health Investors (NHI) paid $3.64 per share in dividends during fiscal year 2025.

National Health Investors (NHI) has a return on equity of 9.3% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

National Health Investors (NHI) recorded an outflow of $57.5M in free cash flow during fiscal year 2025. This represents a -215.3% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

National Health Investors (NHI) generated $236.6M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

National Health Investors (NHI) had $2.8B in total assets as of fiscal year 2025, including both current and long-term assets.

National Health Investors (NHI) invested $294.0M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

National Health Investors (NHI) had 48M shares outstanding as of fiscal year 2025.

National Health Investors (NHI) had a liabilities-to-equity ratio of 0.83 as of fiscal year 2025, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity. No debt-to-equity ratio is shown for fiscal year 2025, because the filing data we hold for that year carries no long-term debt figure.

National Health Investors (NHI) had a return on assets of 5.1% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

National Health Investors (NHI) trades at 4.3x earnings, its market capitalization divided by $697.5M net income, trailing 12 months to September 30, 2026. The market capitalization is $3.0B as of Nov 19, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

National Health Investors (NHI) trades at 6.6x sales, its market capitalization divided by $455.8M revenue, trailing 12 months to September 30, 2026. The market capitalization is $3.0B as of Nov 19, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

National Health Investors (NHI) has a Piotroski F-Score of 4 out of 6 computable signals; 3 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

National Health Investors (NHI) has an earnings quality ratio of 1.66x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

National Health Investors (NHI) scores 50 out of 100 on our Financial Health Score, indicating moderate standing within its REITs peer group. The score is the average of six dimensions (FFO Margin, FFO Growth, Leverage, Interest Cov., AFFO Margin, Dividend Cov.), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. For National Health Investors it averages the 4 of 6 dimensions that can be computed; the others are left out rather than counted as zero. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top